Priya Bansal

3 weeks ago | healio.com | Isabella Hornick |Kristen Dowd |Priya Bansal

Key takeaways: To accelerate the prior authorization process, physicians could use the electronic prior authorization system and/or train more staff members. Successful prior authorizations require close attention to detail. SAN DIEGO — Getting prior authorization for medications can be a struggle in allergy and asthma care, but creating templates and paying attention to detail can speed up the process and lead to more success, according to a presentation here.

Nov 29, 2024 | hcplive.com | Kristin Sokol |Vivian P Hernandez-Trujillo |Priya Bansal

OpinionPodcastNovember 29, 2024Author(s):, Patient education and shared decision-making enhance treatment alignment with patient values and preferences, improving therapy outcomes. Unmet needs in CSU management include more effective treatments and a deeper understanding of disease mechanisms. The field of CSU management is advancing with biologics and personalized medicine approaches, offering new therapeutic options.

Nov 22, 2024 | hcplive.com | Kristin Sokol |Vivian P Hernandez-Trujillo |Priya Bansal

OpinionPodcastNovember 22, 2024Author(s):, Biologics, especially monoclonal antibodies, provide targeted, personalized treatment options in CSU management, improving efficacy and safety profiles. BTK inhibitors offer a novel therapeutic approach by modulating B-cell receptor signaling, potentially benefiting patients unresponsive to conventional therapies. Future advancements in CSU management may focus on precision medicine to optimize biologics and BTK inhibitors, enhancing patient outcomes.

Nov 22, 2024 | hcplive.com | Kristin Sokol |Vivian P Hernandez-Trujillo |Priya Bansal

OpinionPodcastNovember 22, 2024Author(s):, Biologics for CSU face challenges including high costs, side effects, and the necessity for accurate patient selection to ensure treatment efficacy. BTK is a key player in mast cell degranulation, making it an ideal target for CSU treatment by potentially reducing histamine release. Targeting BTK offers a more specific treatment approach for CSU, addressing the condition's underlying pathophysiology.

Nov 19, 2024 | healio.com | Richard Gawel |Kristen Dowd |Priya Bansal

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Shortcuts are available to streamline electronic health record inputs. EHRs should integrate immunotherapy modules. Real-time benefit checks improve the prior authorization process.